DCF — KAISER SUNNYSIDE MEDICAL CENTER
Enterprise Value: $0.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$0.0M
Enterprise Value
$0.0M
PV of Cash Flows
$0.0M
PV of Terminal Value
$0.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $0.0M | $0.0M | 1.0% | $0.0M | $0.0M |
| Year 2 | $0.0M | $0.0M | 1.0% | $0.0M | $0.0M |
| Year 3 | $0.0M | $0.0M | 3.0% | $0.0M | $0.0M |
| Year 4 | $0.0M | $0.0M | 3.0% | $0.0M | $0.0M |
| Year 5 | $0.0M | $0.0M | 3.0% | $0.0M | $0.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $0.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base0.0
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.0
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5